Therapy Areas: Cardiovascular
Philips launches ECG AI Marketplace to streamline cardiac diagnostics
17 July 2025 -

Dutch health technology company Royal Philips (NYSE:PHG) (AEX:PHIA) announced on Thursday that it has launched the Philips ECG AI ...

AstraZeneca's Baxdrostat meets all endpoints in pivotal Phase III hypertension trial
14 July 2025 - Science-led biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) reported on Monday that baxdrostat met its primary and all secondary endpoints in the Phase III...
Rocket Pharmaceuticals receives FDA clearance for gene therapy targeting BAG3-associated dilated cardiomyopathy
30 June 2025 - Late-stage biotechnology company Rocket Pharmaceuticals Inc (NASDAQ:RCKT) announced on Monday that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug app...
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
26 June 2025 - Accord Healthcare Inc, a US-based generic pharmaceutical company, announced on Wednesday that it has added Dehydrated Alcohol Injection to its line of cardiovascular drugs.Accord's...
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
25 June 2025 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of oncology, autoimmune, cardiov...
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
25 June 2025 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes and sells generic medicines in the United States, announced on Tuesday tha...